ZOCCALI, CARMINE
 Distribuzione geografica
Continente #
AS - Asia 10.376
NA - Nord America 5.287
EU - Europa 2.462
SA - Sud America 2.164
Continente sconosciuto - Info sul continente non disponibili 224
AF - Africa 173
OC - Oceania 19
Totale 20.705
Nazione #
US - Stati Uniti d'America 4.937
SG - Singapore 4.730
CN - Cina 1.936
BR - Brasile 1.693
VN - Vietnam 1.123
HK - Hong Kong 1.095
RU - Federazione Russa 689
FR - Francia 652
IT - Italia 510
KR - Corea 346
BD - Bangladesh 289
JP - Giappone 171
IN - India 163
CA - Canada 143
AR - Argentina 129
GB - Regno Unito 122
CO - Colombia 108
DE - Germania 103
NL - Olanda 90
MX - Messico 79
ID - Indonesia 78
EC - Ecuador 70
FI - Finlandia 59
IL - Israele 52
SA - Arabia Saudita 50
VE - Venezuela 50
IQ - Iraq 49
ZA - Sudafrica 48
MY - Malesia 38
UA - Ucraina 38
TR - Turchia 37
PK - Pakistan 32
PY - Paraguay 31
MA - Marocco 30
ES - Italia 29
PL - Polonia 29
CL - Cile 27
JM - Giamaica 25
PE - Perù 24
UZ - Uzbekistan 24
CR - Costa Rica 23
UY - Uruguay 23
TH - Thailandia 22
PH - Filippine 21
NP - Nepal 18
TT - Trinidad e Tobago 18
EG - Egitto 17
AU - Australia 16
DZ - Algeria 16
HN - Honduras 15
JO - Giordania 15
SE - Svezia 14
AE - Emirati Arabi Uniti 13
KE - Kenya 13
TN - Tunisia 13
AZ - Azerbaigian 12
IE - Irlanda 12
NI - Nicaragua 12
GT - Guatemala 11
AL - Albania 10
LT - Lituania 10
TW - Taiwan 10
BG - Bulgaria 9
KZ - Kazakistan 9
AT - Austria 8
BO - Bolivia 8
HR - Croazia 8
LB - Libano 8
RS - Serbia 8
AO - Angola 7
CZ - Repubblica Ceca 7
KG - Kirghizistan 7
BE - Belgio 6
RO - Romania 6
DO - Repubblica Dominicana 5
HU - Ungheria 5
OM - Oman 5
PA - Panama 5
PT - Portogallo 5
BB - Barbados 4
CH - Svizzera 4
EE - Estonia 4
ET - Etiopia 4
LV - Lettonia 4
MD - Moldavia 4
PS - Palestinian Territory 4
BY - Bielorussia 3
CI - Costa d'Avorio 3
GR - Grecia 3
LK - Sri Lanka 3
NG - Nigeria 3
PR - Porto Rico 3
BA - Bosnia-Erzegovina 2
CG - Congo 2
DK - Danimarca 2
GE - Georgia 2
IM - Isola di Man 2
KW - Kuwait 2
MN - Mongolia 2
MU - Mauritius 2
Totale 20.440
Città #
Singapore 2.810
Hong Kong 1.085
Santa Clara 811
Hefei 768
Lauterbourg 576
San Jose 550
Ho Chi Minh City 393
Ashburn 391
Seoul 341
Beijing 275
Hanoi 263
Los Angeles 153
New York 146
São Paulo 116
Tokyo 113
Dallas 108
Buffalo 63
Rio de Janeiro 61
Milan 57
Council Bluffs 56
Chicago 54
Da Nang 54
Rome 49
Minamishinagawa 48
Brasília 44
Frankfurt am Main 44
Haiphong 44
Brooklyn 41
Toronto 41
Helsinki 38
Belo Horizonte 33
Curitiba 33
Philadelphia 31
Atlanta 30
Guayaquil 30
Houston 28
Orem 28
Bengaluru 27
Bogotá 27
Dhaka 27
Naples 27
Phoenix 27
Salvador 26
The Bronx 26
Thái Bình 26
Biên Hòa 22
Hải Dương 22
Miami 22
Campinas 21
Charlotte 21
San José 21
Tashkent 21
Newark 20
Porto Alegre 20
Quito 20
Shanghai 20
Warsaw 20
Baghdad 19
Queens 19
Johannesburg 18
Lappeenranta 18
Las Vegas 18
Montreal 18
Lima 17
Amsterdam 16
Bangkok 16
Elk Grove Village 16
Guangzhou 16
Kuala Lumpur 16
Manaus 16
Medellín 16
Montevideo 16
Pittsburgh 16
Riyadh 16
Shenzhen 16
Cleveland 15
Tampa 15
Amman 14
Bắc Ninh 14
Joinville 14
Belém 13
Cape Town 13
Guarulhos 13
Istanbul 13
Juiz de Fora 13
Memphis 13
New Delhi 13
San Antonio 13
Sorocaba 13
São Bernardo do Campo 13
Thái Nguyên 13
Bologna 12
Catania 12
Chennai 12
Dammam 12
Denver 12
Fortaleza 12
Jacksonville 12
Jeddah 12
London 12
Totale 10.895
Nome #
Il rapporto vita fianchi predice la mortalità nei pazienti in dialisi in maniera opposta rispetto all'indice di massa corporea. 688
Inflammation is an amplifier of lung congestion by high lv filling pressure in hemodialysis patients: a longitudinal study 115
Is there long-term value of pathology scoring in immunoglobulin A nephropathy? A validation study of the Oxford Classification for IgA Nephropathy (VALIGA) update 101
Can the assessment of ultrasound lung water in haemodialysis patients be simplified? 95
Epidemiology of hyperkalemia in CKD patients under nephrological care: a longitudinal study 94
Treatment-resistant hypertension in the hemodialysis population: a 44-h ambulatory blood pressure monitoring-based study 91
I test diagnostici e l'analisi della curva ROC. 89
Socioeconomic Status and Clinical Outcomes in Chronic Kidney Disease: Bootstrap Validation of a Simple Indicator 88
Long-Term Changes in Sleep Disordered Breathing in Renal Transplant Patients: Relevance of the BMI 87
Comparative effectiveness of different antihypertensive agents in kidney transplantation: a systematic review and meta-analysis 84
Mutations in the GLA Gene and LysoGb3: Is It Really Anderson-Fabry Disease? 84
Long-term blood pressure monitoring by office and 24-h ambulatory blood pressure in renal transplant patients: a longitudinal study 79
Sympathetic nerve traffic overactivity in chronic kidney disease: a systematic review and meta-analysis 78
Be careful with ecological associations 76
Office, standardized and 24-h ambulatory blood pressure and renal function loss in renal transplant patients 76
Major adipose tissue Cytokines Leptin and Adiponectin interact with central obesity in explaining the variability in all-cause and cardiovascular death in a high risk population. 74
Serum gamma-glutamyltransferase, oxidized LDL and mortality in the elderly 73
Assessment of hypertension in kidney transplantation by ambulatory blood pressure monitoring: a systematic review and meta-analysis 73
Effect of inflammation by acute sepsis on intact fibroblast growth factor 23 (iFGF23) and asymmetric dimethyl arginine (ADMA) in CKD patients 70
A polymorphism in the major gene regulating serum uric acid associates with clinic SBP and the white-coat effect in a family-based study 70
Systematic DNA Study for Fabry Disease in the End Stage Renal Disease Patients from a Southern Italy Area 70
ACE genotype and ACE inhibitors induced renoprotection in chronic proteinuric nephropathies 69
Blood Pressure (Bp) Control And Left Ventricular Hypertrophy (Lvh) In Chronic Renal Insufficiency (Cri): The Italian Multicentre Survey. 68
Reducing salt intake by urine chloride self-measurement in non-compliant patients with chronic kidney disease followed in nephrology clinics: a randomized trial 68
Patterns of pharmacologic treatment of hypertension in CKD patients stage 3-5: data from the SIR-SIN Study. 66
Asymmetric and Symmetric Dimethylarginine and Sympathetic Nerve Traffic after Renal Denervation in Patients with Resistant Hypertension 66
Nocturnal Hypertension and Altered Night-Day BP Profile and Atherosclerosis in Renal Transplant Patients 65
Sleep-Disordered Breathing and 24-Hour Ambulatory Blood Pressure Monitoring in Renal Transplant Patients: Longitudinal Study 65
The dominant prognostic value of physical functioning among quality of life domains in end-stage kidney disease 65
Pulse Wave Velocity and Prognosis in End-Stage Kidney Disease 64
Hypertension in kidney transplantation: a consensus statement of the ‘hypertension and the kidney’ working group of the European Society of Hypertension 64
A Genetic Marker of Uric Acid Level, Carotid Atherosclerosis, and Arterial Stiffness: A Family-Based Study 64
The bidirectional link between left ventricular hypertrophy and chronic kidney disease. A cross lagged analysis 64
Hyperhomocysteinemia and arteriovenous fistula thrombosis in hemodialysis patients 63
Haemoglobin and endothelium-dependent vasodilation in uncomplicated, untreated subjects with essential hypertension. 62
Modalità di stima del filtrato glomerulare (FG) e inizio della dialisi. Dati preliminari dello studio SIR-SIN della Società Italiana di Nefrologia nella popolazione affetta da IRC in terapia conservativa. 62
Phosphate and the renoprotective effect of ace inhibition: a post-hoc analysis of the Rein Trial. 62
An introduction to joint models—applications in nephrology 62
The sirtuinl gene associates with left ventricular myocardial hypertrophy and remodeling in two chronic kidney disease cohorts: a longitudinal study 62
Reporting of interaction. 61
Sindrome metabolico y aspectos epidemiologicos de la enfermedad renal cronica. 61
Conducting correlation analysis: important limitations and pitfalls 61
Renal artery stenosis is an independent predictor of left ventricular hypertrophy. 60
CAN THE ASSESSMENT OF ULTRASOUND LUNG WATER IN HEMODIALYSIS PATIENTS BE SIMPLIFIED? 58
Effect of a home based, low intensity, physical exercise program in older adults dialysis patients: a secondary analysis of the EXCITE trial 58
Tissue inhibitor of metalloproteinases (TIMP-1), genetic markers of insulin resistance and cardiomyopathy in patients with kidney failure 58
Serum Erythroferrone Levels Associate with Mortality and Cardiovascular Events in Hemodialysis and in CKD Patients: A Two Cohorts Study 58
Sleep Disordered Breathing in Renal Transplant Patients. 57
Matching, an appealing method to avoid confounding? 56
Creatinine calibration and CKD staging 56
Adiponectin and Leptin in chronic kidney disease: causal factors or mere risk markers? 56
Le misure di frequenza negli studi epidemiologici: l incidenza e la prevalenza. 56
Association of IL-6 and a functional polymorphism in the IL-6 gene with cardiovascular events in patients with CKD 56
FGF23 and the PTH response to paricalcitol in chronic kidney disease 56
La necessità di estendere la nefrologia al territorio. 55
Pro- and anti-inflammatory cytokine gene expression in subcutaneous and visceral fat in severe obesity 55
Blood pressure monitoring in kidney transplantation: a systematic review on hypertension and target organ damage 55
Reclassification of chronic kidney disease patients for end-stage renal disease risk by proteinuria indexed to estimated glomerular filtration rate: multicentre prospective study in nephrology clinics 55
A polymorphismin a major antioxidant gene (Kelch-like ECH-associated protein1) predicts incident cardiovascular events in chronic kidney disease patients: an exploratory study 54
Radiation dose from medical imaging in end stage renal disease patients: a Nationwide Italian Survey 54
Sympathetic neural overdrive in congestive heart failure and its correlates: systematic reviews and meta-analysis 53
Waist circumference but not Body Mass Index (BMI) reflects the inflammation in dialysis patients. 52
Prevalence and burden of chronic kidney disease among the general population and high-risk groups in Africa: a systematic review 52
Synergism between asymmetric dimethylarginine (ADMA) and a genetic marker of uric acid in CKD progression 52
Renal safety of catheter-based renal denervation: systematic review and meta-analysis 52
Intact FGF23 and ?-klotho during acute inflammation/sepsis in CKD patients 52
Biomarkers of CVD risk in CKD 51
Chronic kidney disease certification process manual by the Italian Society of Nephrology (SIN): part II: programme management and clinical information management. 51
Prognostic values of left ventricular mass index in chronic kidney disease patients 51
Inflammation downregulates FGF23 in chronic kidney disease (CKD) patients. 50
Neuropeptide Y and chronic kidney disease progression: a cohort study 50
Sample size calculations: basic principles and common pitfalls. 48
Traditional and emerging cardiovascular and renal risk factors: an epidemiologic perspective. 48
Insulin resistance in chronic kidney disease: a systematic review 48
Neuropeptide Y receptor Y2 gene polymorphism interacts with plasma neuropeptide Y levels in predicting left ventricular hypertrophy in dialysis patients 47
Vitamin D receptor activation raises soluble thrombomodulin levels in chronic kidney disease patients: a double blind, randomized trial 47
When impact trials are not feasible: alternatives to study the impact of prediction models on clinical practice 47
Plasma cytokines, glomerular filtration rate and adipose tissue cytokines gene expression in chronic kidney disease (CKD) patients. 47
Resistin and all-cause and cardiovascular mortality: Effect modification by adiponectin in end-stage kidney disease patients 47
Biosimilars and biopharmaceuticals: what the nephrologists need to know--a position paper by the ERA-EDTA Council. 46
The burden of progressive renal function loss, with special intention to European situation. 46
Atherosclerosis and the Glu298Asp polymorphism of the eNOS gene in white patients with end stage renal disease. 46
Mendelian randomization: a new approach to studying epidemiology in ESRD 46
Points of attention when conducting etiological research 46
Detection of pulmonary congestion by chest ultrasound (US) in dialysis patients. 45
Circulating E-selectin as a risk marker in patients with end-stage renal disease 45
eNOS and Caveolin-1 Gene Polymorphisms Interaction and Intima Media Thickness: A Proof of Concept Study in ESRD Patients. 45
Stenting of renal artery stenosis in coronary artery disease (RAS-CAD) study: a prospective, randomized TRIAL. 44
Stabilità cardiovascolare nelle terapie convettive. 44
Effects: Causal effects. 44
Obesity and the epidemiology and prevention of kidney disease: waist circumference versus body mass index. 44
Differences between GFR estimation by an equation based on creatinine and one based on Cystatine C 44
Left ventricular mass monitoring in the follow-up of dialysis patients: prognostic value ventricular hypertrophy progression. 44
Abdominal obesity modifies the risk of hypertriglyceridemia for a all-cause and cardiovascular mortality in hemodialysis patients 44
Waist circumference modifies the relationship between the adipose tissue cytokines leptin and adiponectin and all-cause and cardiovascular mortality in haemodialysis patients. 43
The ENPP1 Q121 variant predicts major cardiovascular events in high-risk individuals: Evidence for interaction with obesity in diabetic patients 43
Kidney Disease: Improving Global Outcomes (KDIGO) Transplant Work Group. KDIGO clinical practice guideline for the care of kidney transplant recipients. 43
Effectiveness of cold HD for the prevention of HD hypotension and mortality in the general HD population 43
Valore prognostico della disfunzione sistolica asintomatica nei pazienti in dialisi. 42
Association of a polymorphism in a gene encoding a urate transporter with ckd progression 42
Totale 6.586
Categoria #
all - tutte 76.464
article - articoli 42.114
book - libri 92
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.156
Totale 119.826


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202495 0 0 0 0 0 0 0 0 47 9 37 2
2024/20256.406 40 48 577 419 816 45 100 198 124 123 2.085 1.831
2025/202611.776 531 907 1.149 1.731 1.891 295 1.861 847 1.310 600 384 270
2026/20272.428 590 536 1.302 0 0 0 0 0 0 0 0 0
Totale 20.705